| Sign In to gain access to subscriptions and/or personal tools. |
Review: Diabetic dyslipidaemia — the case for using statinsGadsby Warwick Diabetes Care, The University of Warwick, Coventry, CV7 4AL, UK, rgadsby{at}doctors.org.uk Type 2 diabetes is associated with an increased risk of coronary heart disease (CHD). The association between CHD and abnormal plasma lipid levels has led current guidelines to recommend pharmacological modification of the lipid profile. Statins are particularly effective at reducing cholesterol levels, with additional benefits on other components of the lipid profile. Lipid-modifying therapy should be used routinely to reduce the risk of CHD in patients with type 2 diabetes.
Key Words: cardiovascular disease coronary heart disease dyslipidaemia statins type 2 diabetes.
The British Journal of Diabetes & Vascular Disease, Vol. 3, No. 6,
402-407 (2003) |
||||